SCHEMBL4250143

SCHEMBL4250143

COCCOCc1c(C(=O)NC[C@@H](C)Oc2ccc(C(=S)NO)cc2)oc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.50
HDAC3 O15379 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
LMNA P02545 5/20 0.44
MAPT P10636 4/20 0.44
KDM4E B2RXH2 4/20 0.44
HTT P42858 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442406 0.92 HDAC3 (0.53) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL442407 0.92 HDAC3 (0.53) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4251763 0.85 HDAC3 (0.62) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4253254 0.81 HDAC3 (0.44) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4247069 0.80 LMNA (0.58) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4254186 0.79 HDAC3 (0.65) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL445144 0.77 HDAC3 (0.73) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4255373 0.77 HDAC3 (0.62) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4251047 0.76 HDAC3 (0.61) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL4254747 0.76 HDAC1 (0.59) L3MBTL1HDAC3HDAC1HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC8, HDAC3 L3MBTL1 1527/4885HDAC3 3/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.